Development of quantitative structure activity relationships for the binding affinity of methoxypyridinium cations

Jason A Morrill1, Joseph J Topczewski2, Alexander M Lodge2

  • 1Department of Chemistry, William Jewell College, 500 College Hill, Liberty, MO 64068, United States.

Insights

Researchers developed Quantitative Structure-Activity Relationships (QSARs) to create therapies for organophosphorus (OP) poisoning victims, even after the toxic effects have aged. This new approach targets OP-inhibited acetylcholinesterase (AChE) in its aged state.

Area of Science:

  • Toxicology
  • Medicinal Chemistry
  • Computational Chemistry

Background:

  • Organophosphorus (OP) compounds are highly toxic pesticides and chemical warfare agents.
  • Current therapies for OP exposure target inhibited acetylcholinesterase (AChE) but are ineffective once AChE undergoes aging.
  • There is a critical need for treatments effective against aged AChE inhibition.

Purpose of the Study:

  • To develop Quantitative Structure-Activity Relationships (QSARs) for designing therapies against aged organophosphorus (OP) agent intoxication.
  • To identify molecular descriptors that predict the efficacy of OP-inhibiting compounds in the aged state.

Main Methods:

  • Utilized the AM1 semiempirical quantum mechanical method.
  • Employed the CODESSA (Comprehensive Descriptors for Structural and Statistical Analysis) program for descriptor generation and analysis.
  • Developed multiple correlation QSAR models using a training set of 38 ligands.

Main Results:

  • Achieved a high coefficient of determination (R(2)=0.9359) for the QSAR model on the training set.
  • Validated the model's predictive power with a random test set, yielding R(2)=0.9236.
  • Established a robust QSAR equation for predicting the activity of OP inhibitors in the aged state.

Conclusions:

  • The developed QSAR models provide a valuable tool for designing novel therapeutic agents against aged organophosphorus (OP) intoxication.
  • This research paves the way for effective treatments for victims exposed to OP agents, addressing limitations of current therapies.
  • Computational chemistry approaches, like QSAR, are crucial for accelerating the development of antidotes for toxic exposures.

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
3.0K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.5K
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
2.0K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
3.0K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
4.1K